TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Yesterday

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 4:57 PM

Thu Feb 23

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 11:05 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 9:30 PM

Wed Feb 22

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 2:51 AM

Mon Feb 20

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 9:44 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 2:41 PM

Fri Feb 17

Hidden Gems Boards Post

TMFBiologyFool replied to the Hidden Gems boards. 3:46 PM

Wed Feb 15

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 6:15 PM

Pro Boards Post

TMFBiologyFool replied to the Pro boards. 6:04 PM

NL

Article

TMFBiologyFool published an article 4:37 PM

Why Genomic Health Inc. Jumped Higher Today

The genetic-test maker revealed a solid fourth quarter, with the promise of more growth to come.

NL

Article

TMFBiologyFool published an article 3:55 PM

Genomic Health, Inc. Swings to a Profit

The genetic-test maker gets into the black as it expands test sales outside of the U.S.

Rule Breakers article.

TMFBiologyFool published an update. 2:13 PM

Tue Feb 14

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 1:25 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 1:03 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 3:27 AM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 2:48 AM

Mon Feb 13

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:50 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 5:21 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 5:05 PM

NL

Article

TMFBiologyFool published an article 3:57 PM

Seattle Genetics Earnings: Waiting on ECHELON

2017 is looking like a transition year for the biotech.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 52.35
Player Rank 35562 out of 74626
Score -292.91
Score Change Today +24.00
Accuracy 67.14%
Active Picks 71
Total Picks 215
Best Pick UNH (+301.86)
Worst Pick INCY (-1287.09)
Average Score per Pick -1.36
Charms Earned 2
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1402
Recs Received 2231
People who have rec'd these posts 635
Recs to Posts Ratio (last 30 days) 4.40
Threads Started 143
Threads Started Percentage 10.20 %
Most Frequent Board Motley Fool Supernova
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 57.70 %
Show TMFBiologyFool’s 10 Latest Posts